Andira Medicine Inc. research brief
CIK 1916630
Generated Nov. 18, 2026, 4:58 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: North Vancouver British Columbia, Canada. Reported legal jurisdiction: BRITISH COLUMBIA, CANADA. These do not establish investor residence or where funds were deployed.
- Nov. 6, 2026 · D/A · 0000912282-26-001433 · Source evidence
Reported offering amount: 220000 USD. Reported amount sold: 220000 USD.
- Oct. 9, 2026 · D · 0000912282-26-001352 · Source evidence
Reported offering amount: 120000 USD. Reported amount sold: 120000 USD.
- Sept. 4, 2026 · D/A · 0000912282-26-001224 · Source evidence
Reported offering amount: 1619844 USD. Reported amount sold: 809922 USD.
- Aug. 18, 2026 · D · 0000912282-26-001123 · Source evidence
Reported offering amount: 100000 USD. Reported amount sold: 100000 USD.
- March 12, 2026 · D · 0000912282-26-000427 · Source evidence
Reported offering amount: 152390 USD. Reported amount sold: 152390 USD.
- Sept. 5, 2025 · D/A · 0000912282-25-000969 · Source evidence
Reported offering amount: 1619844 USD. Reported amount sold: 809922 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Andira Medicine Inc. research brief,” CIK 1916630, retrieved Nov. 18, 2026, 4:58 a.m.. Cite the specific accessions used. No amounts have been summed.